Christel Thauvin-Robinet1, Jaclyn S Lee2, Estelle Lopez3, Vicente Herranz-Pérez4, Toshinobu Shida5, Brunella Franco6, Laurence Jego3, Fan Ye5, Laurent Pasquier7, Philippe Loget8, Nadège Gigot9, Bernard Aral9, Carla A M Lopes10, Judith St-Onge9, Ange-Line Bruel3, Julien Thevenon11, Susana González-Granero4, Caroline Alby12, Arnold Munnich13, Michel Vekemans13, Frédéric Huet11, Andrew M Fry10, Sophie Saunier14, Jean-Baptiste Rivière9, Tania Attié-Bitach13, Jose Manuel Garcia-Verdugo4, Laurence Faivre11, André Mégarbané15, Maxence V Nachury5. 1. 1] Equipe d'Accueil 4271 Génétique des Anomalies du Développement, Fédération Hospitalo-Universitaire, Université de Bourgogne, Dijon, France. [2] Centre de Référence Maladies Rares "Anomalies du Développement et Syndromes Malformatifs" de l'Est, Centre de Génétique et Pédiatrie 1, Hôpital d'Enfants, Centre Hospitalier Universitaire Dijon, Dijon, France. [3]. 2. 1] Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, California, USA. [2]. 3. Equipe d'Accueil 4271 Génétique des Anomalies du Développement, Fédération Hospitalo-Universitaire, Université de Bourgogne, Dijon, France. 4. 1] Laboratorio de Neurobiología Comparada, Instituto Cavanilles, Universitat de València, Centro Investigación Biomédica en Red Enfermedades Neurodegenerativas, Valencia, Spain. [2] Unidad Mixta de Esclerosis Múltiple y Neurorregeneración, Instituto de Investigación Sanitaria Hospital La Fe, Universitat de València, Valencia, Spain. 5. Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, California, USA. 6. 1] Telethon Institute of Genetics and Medicine (TIGEM), Naples, Italy. [2] Department of Medical Translational Sciences, Division of Pediatrics, Federico II University of Naples, Naples, Italy. 7. Centre de Référence Maladies Rares "Anomalies du Développement et Syndromes Malformatifs" de l'Ouest, Unité Fonctionnelle de Génétique Médicale, Centre Hospitalier Universitaire Rennes, Rennes, France. 8. Laboratoire d'Anatomie-Pathologie, Centre Hospitalier Universitaire Rennes, Rennes, France. 9. 1] Equipe d'Accueil 4271 Génétique des Anomalies du Développement, Fédération Hospitalo-Universitaire, Université de Bourgogne, Dijon, France. [2] Laboratoire de Génétique Moléculaire, Plateau Technique de Biologie, Centre Hospitalier Universitaire Dijon, Dijon, France. 10. Department of Biochemistry, University of Leicester, Leicester, UK. 11. 1] Equipe d'Accueil 4271 Génétique des Anomalies du Développement, Fédération Hospitalo-Universitaire, Université de Bourgogne, Dijon, France. [2] Centre de Référence Maladies Rares "Anomalies du Développement et Syndromes Malformatifs" de l'Est, Centre de Génétique et Pédiatrie 1, Hôpital d'Enfants, Centre Hospitalier Universitaire Dijon, Dijon, France. 12. 1] INSERM U781, Institut IMAGINE, Hôpital Necker-Enfants Malades, Paris, France. [2] Paris Descartes-Sorbonne Paris Cité University, Institut IMAGINE, Paris, France. 13. 1] INSERM U781, Institut IMAGINE, Hôpital Necker-Enfants Malades, Paris, France. [2] Paris Descartes-Sorbonne Paris Cité University, Institut IMAGINE, Paris, France. [3] Département de Génétique, Hôpital Necker-Enfants Malades, Paris, France. 14. 1] Paris Descartes-Sorbonne Paris Cité University, Institut IMAGINE, Paris, France. [2] INSERM, UMRS 1163, Laboratory of Inherited Kidney Diseases, Paris, France. 15. Unité de Génétique Médicale, Faculté de Médecine, Université Saint-Joseph, Beirut, Lebanon.
Abstract
Centrioles are microtubule-based, barrel-shaped structures that initiate the assembly of centrosomes and cilia. How centriole length is precisely set remains elusive. The microcephaly protein CPAP (also known as MCPH6) promotes procentriole growth, whereas the oral-facial-digital (OFD) syndrome protein OFD1 represses centriole elongation. Here we uncover a new subtype of OFD with severe microcephaly and cerebral malformations and identify distinct mutations in two affected families in the evolutionarily conserved C2CD3 gene. Concordant with the clinical overlap, C2CD3 colocalizes with OFD1 at the distal end of centrioles, and C2CD3 physically associates with OFD1. However, whereas OFD1 deletion leads to centriole hyperelongation, loss of C2CD3 results in short centrioles without subdistal and distal appendages. Because C2CD3 overexpression triggers centriole hyperelongation and OFD1 antagonizes this activity, we propose that C2CD3 directly promotes centriole elongation and that OFD1 acts as a negative regulator of C2CD3. Our results identify regulation of centriole length as an emerging pathogenic mechanism in ciliopathies.
Centrioles are microtubule-based, barrel-shaped structures that initiate the assembly of centrosomes and cilia. How centriole length is precisely set remains elusive. The microcephaly protein CPAP (also known as MCPH6) promotes procentriole growth, whereas the oral-facial-digital (OFD) syndrome protein OFD1 represses centriole elongation. Here we uncover a new subtype of OFD with severe microcephaly and cerebral malformations and identify distinct mutations in two affected families in the evolutionarily conserved C2CD3 gene. Concordant with the clinical overlap, C2CD3 colocalizes with OFD1 at the distal end of centrioles, and C2CD3 physically associates with OFD1. However, whereas OFD1 deletion leads to centriole hyperelongation, loss of C2CD3 results in short centrioles without subdistal and distal appendages. Because C2CD3 overexpression triggers centriole hyperelongation and OFD1 antagonizes this activity, we propose that C2CD3 directly promotes centriole elongation and that OFD1 acts as a negative regulator of C2CD3. Our results identify regulation of centriole length as an emerging pathogenic mechanism in ciliopathies.
Centrioles are microtubule-based barrel-shaped structures that initiate the assembly of centrosomes and cilia[1,2]. How centriole length is precisely set remains elusive. The microcephaly protein CPAP/MCPH6 promotes procentriole growth[3-5] while the oral-facial-digital syndrome protein OFD1 represses centriole elongation[6,7]. Here, we uncover a novel subtype of OFD with severe microcephaly and cerebral malformations and identify distinct mutations in two families in the evolutionarily conserved C2CD3 gene. Concordant with the clinical overlap, C2cd3 co-localizes with Ofd1 at the distal end of centrioles and C2CD3 physically associates with OFD1. However, in opposition to Ofd1, loss of C2cd3 results in the shortening of centrioles and the loss of sub-distal and distal appendages. Since C2cd3 overexpression triggers centriole hyperelongation and Ofd1 antagonizes this activity, we propose that C2cd3 directly promotes centriole elongation and that Ofd1 acts as a negative regulator of C2cd3. Our results identify centriole length regulation as an emerging pathomechanism in ciliopathies.
Results and Discussion
Oral-facial-digital syndromes (OFD) are ciliopathies characterized by malformations of the face, oral cavity, and digits[8]. A 4-year-old male patient born from consanguineous parents presented with canonical OFD syndrome as well as severe microcephaly, micropenis and severe intellectual disability (Fig. 1a, b and Supplementary Table 1), indicative of an unclassified OFD syndrome. Brain MRI revealed the presence of Molar Tooth Sign (MTS, a cerebellar anomaly characteristic of Joubert syndrome (JBTS) and related disorders[9]), and several other cerebral malformations (Fig. 1c–e and Supplementary Table 1). His younger sister presented with similar anomalies and cardiac malformation, leading to neonatal death. Homozygosity mapping revealed a candidate region of 4 Mb at 11q13.4-q14.1 (Supplementary Fig. 1a), and coupled exome sequencing identified a homozygous nonsense mutation in the C2CD3 gene (NM_015531.4: c.184C>T; p.Arg62* in exon 2), which was confirmed by Sanger sequencing and was found heterozygous in his parents (Supplementary Fig. 1b).
Figure 1
Clinical presentations of OFD patients with mutations in C2CD3
(a–e) Characterization of the 4 year-old patient (case 1) showing microcephaly with trigonocephaly, facial dysmorphism including telecanthus, up-slanting palpebral fissures and microretrognathia (a), bilateral broad duplicated and deviated hallux (b), and brain MRI with corpus callosum hypoplasia (c), MTS (d), subarachnoid cysts in the right occipital lobe and the posterior fossa (d,e), and incomplete myelinisation of the white matter (c–e). Informed consent was obtained from the patient’s family.
(f–j) Pictures of the 22 wg fetus (case 2) showing bilateral hand postaxial polydactyly (f) and broad duplicated hallux (g), and X-rays with normal thorax (h) and postaxial polydactyly of the hands (i,j).
(k) Domain organization of C2CD3 (C2 calcium-dependent domain containing 3). The six orange ovals correspond to canonical PKC-C2 domains and the yellow oval is the signature C2CD3N–C2 domain[10] . Patient mutations are indicated in red on top of the diagram, mouse mutants are displayed under the diagram and peptides identified in LAP-BBS4 preparations are mapped onto the diagram by blue bars. The splice site mutation c.3911-2A>T leads to a four nucleotide frameshift deletion (c.3911_3914delCAAG) predicted to result in a premature stop codon at position 1307.
We next screened the coding exons of C2CD3 for mutations in 34 OFD patients negative for mutations in known OFD-associated genes. We identified a male fetus with compound heterozygous C2CD3 mutations consisting of one missense variation (NM_015531.4:c.3085T>G; p.Cys1029Gly) and a substitution in the splice acceptor consensus sequence of exon 22 (NM_015531.4:c.3911-2A>T). Transcript analysis from the affected fetus showed that the c.3911-2A>T substitution causes splicing of the 5'-end of exon 22 to a downstream cryptic splice site, which leads to a four nucleotide frameshift deletion (NM_015531.4:c.3911_3914delCAAG; p.Ala1304Valfs*3) (Supplementary Fig. 1c–e). In close similarity to the index patient, the second patient exhibited severe microcephaly combined with canonical OFD symptoms (Fig. 1f–j and Supplementary Table 1). Both mutations were absent in the Exome Variant Server (see URLs), and were predicted to be damaging according to Human Splicing Finder or PolyPhen2 (see URLs).C2CD3 encodes a protein with seven C2 domains that is universally conserved in organisms that assemble centrioles or cilia[10] (Fig. 1k). A C2cd3 mutant named Hearty (Hty) was isolated in a screen for Hedgehog signalling in mice and ciliogenesis is severely compromised in C2cd3Hty (hypomorph) or C2cd3Gt (null) animals[11] (Fig. 1k). In remarkable resemblance to OFD syndromes, C2cd3Hty and C2cd3Gt mice exhibit embryonic lethality, exencephaly in the midbrain and posterior forebrain with a characteristic tight mesencephalic flexure, a twisted body axis, pericardial edema, rightward turned heart, and severe polydactyly in all four limbs[11,12]. Thus, together with our finding of C2CD3 mutations in two unrelated OFD patients, these results demonstrate that C2CD3 mutations cause OFD. Based on the unique features of microcephaly and cerebral malformations of the two OFD patients with C2CD3 mutations reported here, we propose the name OFD14 for C2CD3. Together with mutations in TMEM216 reported in Joubert (JBTS2, MIM608091), Meckel-Gruber syndrome (MKS2, MIM603194), and OFD VI (Ref. 13), mutations in C5orf42 in Joubert (JBTS17, MIM614615) and OFD VI (Ref. 14,15) and mutations in TCTN3 identified in OFD IV (OFD4, MIM258860), MKS and JBTS (Ref. 16), our identification of a new OFD subtype with severe cerebral malformations including MTS further reinforces the clinical continuum of the ciliopathy spectrum and the inclusion of OFD in the ciliopathies.Besides its requirement for cilium assembly[11], the function of C2cd3 remains largely elusive. A first clue was provided by the mass spectrometry-based identification of C2CD3 as a BBSome-interacting protein (Fig. 1k and Supplementary Fig. 2a). The BBSome is a complex of proteins mutated in the ciliopathy Bardet-Bield Syndrome (BBS, MIM209900) present in cilia and cytoplasmic granules named centriolar satellites[17-20]. To localize C2cd3, we stably expressed GFP-C2cd3 at low levels in a stable clone of mouse IMCD3-FlpIn kidney cells. While C2cd3 was never detected inside cilia, we detected a robust co-localization of C2cd3 with the core centriolar satellite component PCM-1 (Supplementary Fig. 2b). However, knockdown of C2CD3 in RPE1-hTERT cells and C2cd3 mutations in immortalized mouse embryonic fibroblasts (MEFs) failed to reveal defects in centriolar satellite function (Supplementary Fig. 2c).Besides its localization to centriolar satellites, we consistently found C2cd3 at two to four bright juxtanuclear foci that did not overlap with PCM-1 (Supplementary Fig. 2b, insets). Co-staining with a monoclonal antibody against glutamylated tubulin (GT335) –a modified tubulin found at centrioles and ciliary axonemes– revealed these PCM-1-negative foci of C2cd3 to be centrioles (Supplementary Fig. 3a). Although centriolar satellites deliver proteins such as pericentrin to the centrosome[17,21], inhibiting the movement of centriolar satellites using the microtubule poison nocodazole did not affect C2cd3 abundance at centrioles (Supplementary Fig. 3b).We then mapped the precise location of C2cd3 within centrioles. We frequently observed two juxtaposed dots of C2cd3 associated with a single spot of glutamylated tubulin (Fig. 2a). Since the two juxtaposed foci of C2cd3 were each positive for centrin, which marks the distal lumen of mature and pro- centrioles (Fig. 2b and Supplementary Fig. 4a) and since procentriole microtubules are not polyglutamylated[22], the glutamylated tubulin-negative spot of C2cd3 likely represented the procentriole. Staining cells for Sas-6, a marker of procentrioles but not mature centrioles[23], confirmed that C2cd3 is present at procentrioles (Fig. 2c). In mature centrioles, we found C2cd3 slightly distal to the Ninein-or Odf2-marked subdistal appendages (Fig. 2d and Supplementary Fig. 4b). C2cd3 was precisely located between the Cep164-marked distal appendages (Fig. 2e). Finally, the transition zone[25] marker Cep290 was clearly distal to C2cd3 (Fig. 2f), leading us to conclude that C2cd3 is localized near the distal tip of centrioles. CP110 and Ofd1 have also been localized near the distal end of centrioles, with CP110 marking a slightly more distal location than Ofd1 (Ref. 7), namely the centriole cap whose removal allows for elongation of the ciliary axoneme[26]. C2cd3 perfectly co-localized with Ofd1 (Fig. 2g) and was slightly proximal to CP110 (Fig. 2h).
Figure 2
C2cd3 co-localizes with Ofd1 at the distal end of centrioles and procentrioles and physically interacts with Ofd1
IMCD3-[GFP-C2cd3] cells stained for:
(a) The centriolar marker branched-glutamylated tubulin (GT335, pink).
(b) The distal centriole and procentriole marker Centrin (red).
(c) The procentriole marker Sass6 (red).
(d) Ninein (red, marks the subdistal appendages and the proximal end of the centrioles and procentrioles) and glutamylated tubulin (GT335, pink, marks the ciliary axoneme).
(e) Cep164 (red, marks the distal appendages) and glutamylated tubulin (GT335, pink).
(f) Cep290 (red, marks the transition zone) and glutamylated tubulin (GT335, pink).
(g) Ofd1 (red) and γ-tubulin (pink, marks the pericentriolar material near the proximal part of the centriole).
(h) The distal cap marker CP110 (red) and γ-tubulin (pink).
All cells were treated with nocodazole before processing for immunofluorescence. All scale bars are 1 µm.
(i) Immunoprecipitation of OFD1 from RPE cell extract recovers C2CD3. For the C2CD3 immunoblot, 160 equivalent of eluates and 1 equivalent of lysate were ran on the gel. For the OFD1 immunoblot, 4 equivalent of eluates and 1 equivalent of lysate were ran on the gel. The eluate and lysate panels are cropped from the same film exposure.
(j) GST capture assays. GFP-C2cd3 and MBP-GFP-FKBP (negative control) expressed in HEK cells were captured by bacterially expressed GST fusions to Ofd1 fragments. Captured proteins were detected by immunoblotting for GFP. 80 equivalent of eluates and 1 equivalent of lysate were ran on the gel.
Since C2cd3 co-localizes with Ofd1 and since both of these proteins are mutated in OFD syndromes, we tested whether they physically interact. Using antibodies raised against the endogenous proteins, C2CD3 and OFD1 were found to co-immunoprecipitate out of human RPE cells (Fig. 2i). To further confirm this interaction, GST fusions of Ofd1 fragments were expressed in bacteria, immobilized on beads and used to capture GFP-C2cd3 expressed in HEK cells. Remarkably, the central fragment of Ofd1, which is also responsible for homo-dimerization[27], was found to specifically interact with GFP-C2cd3 (Fig. 2j and Supplementary Fig. 4c). We conclude that C2cd3 forms a complex with Ofd1 at the distal end of centrioles where it co-localizes with other known regulators of centriole elongation such as Centrin[28] or Poc5 (Ref. 29).Since OFD1 and C2CD3 associate physically and cytologically and their encoding genes are mutated in the same syndrome, we hypothesized that C2cd3 removal would mimic loss of Ofd1 and result in centrin-positive hyperelongation of centrioles[7]. Surprisingly, centrin was undetectable in the vast majority of C2cd3Hty and C2cd3Gt centrioles (Fig. 3a, b) even though total centrin levels stayed constant (Supplementary Fig. 5a), in agreement with a recent study[30]. Similarly, glutamylated tubulin staining failed to reveal centriole hyperelongation in C2cd3 mutant MEFs (Fig. 3c). Thus, unlike loss of Ofd1, loss of C2cd3 does not result in elongation of the distal centriole compartment.
Figure 3
Loss of C2cd3 results in the disappearance of distal centriole structures
(a) MEFs derived from heterozygous (+/Gt) and homozygous C2cd3 mutant mice (C2cd3Hty and C2cd3Gt) were stained for γ-tubulin (green) and centrin (red).
(b) Counting of centrin-positive centrioles. Black bars correspond to centrioles strongly positive for centrin (as in the left panel of a), grey bars are for centrioles weakly positive for centrin (as the centriole in the lower right corner of the middle panel of a). Error bars denote standard deviations between microscopy fields. Centrioles were identified by γ-tubulin staining. At least 50 cells of each genotype were counted.
(c) MEFs were stained for polyglutamylated tubulin (GT335, green) and Cep164 (red).
(d) Counting of Cep164-positive mother centrioles. Error bars denote standard deviations between microscopy fields. Cells with at least one spot of Cep164 colocalizing with GT335 were counted as Cep164-positive mother centrioles. At least 50 cells of each genotype were counted.
(e) MEFs were stained for polyglutamylated tubulin (GT335, green) and Odf2 (pink).
(f) Counting of Odf2-positive mother centrioles. Error bars denote standard deviations between microscopy fields. Cells with at least one spot of Odf2 colocalizing with GT335 were counted as Odf2-positive mother centrioles. At least 50 cells of each genotype were counted.
(g) MEFs were stained for γ-tubulin (green) and CPAP (red). CPAP location to the proximal end of centrioles and procentrioles leads to an overlap in signals at these two locations and only one diffraction limited spot of CPAP detected.
(h) Counting of CPAP-positive centrioles. Error bars denote standard deviations between microscopy fields. Centrioles were identified by GT335 staining. At least 50 cells of each genotype were counted.
(i) MEFs were stained for γ-tubulin (green) and Ofd1 (red).
(j) Counting of Ofd1-positive centrioles. Black bars correspond to centrioles strongly positive for Ofd1, grey bars are for centrioles weakly positive for Ofd1. Error bars denote standard deviations between microscopy fields. Centrioles were identified by GT335 staining. At least 50 cells of each genotype were counted.
(k) MEFs were stained for polyglutamylated tubulin (GT335, green) and CP110 (red).
All scale bars are 1 µm.
Remarkably, distal appendages (stained by Cep164, Fig. 3c and d) as well as subdistal appendages (stained by Odf2, Fig. 3e and f) were absent from C2cd3 mutant centrioles. Ninein staining confirmed the absence of subdistal appendages and the intactness of the proximal end of centrioles (Supplementary Fig. 5b). Similarly, CPAP, a marker of the proximal segment of centrioles, was retained in C2cd3 mutants (Fig. 3g and h). Ofd1 levels were greatly reduced at C2cd3 mutant centrioles (Fig 3i and j), suggesting that C2cd3 may recruit Ofd1 to centrioles through their physical interaction. While C2cd3 mutant centrioles lose most markers of the distal centrioles, the centriole cap protein CP110 was still present at the distal end of centrioles (Fig. 3k), concordant with the inability of C2cd3 cells to assemble a primary cilium[11].An appealing explanation for the loss of distal centriole structures in C2cd3 mutant cells is incomplete centriole elongation. Alternatively, it is conceivable that maturation of the distal centriole is affected independently of centriole length alterations. In support of the former hypothesis, the distance between centriole cap and centriole center –measured by fluorescence microscopy– was significantly reduced in C2cd3 cells compared to control cells (Fig. 4a,b). To precisely assess the structural defects of C2cd3 mutant centrioles, we performed thin section electron microscopy on the C2cd3 MEFs. Confirming our immunofluorescence findings, distal and subdistal appendages were absent from C2cd3 centrioles (Fig. 4c–e and Supplementary Fig. 6a,b). Total centriole length was precisely assessed by thin-section EM and we found C2cd3 mutant centrioles to be shorter than controls by ∼150 nm (Fig. 4f). We conclude that C2cd3 is required for the extension of procentrioles into full-length centrioles.
Figure 4
C2cd3 is required for centriole elongation
(a) Gallery of centrioles stained for CP110 (red) and GT335 (green) with the centroid of each fluorescent spot shown as a white cross. Images were deconvolved. Scale bar 0.2 µm.
(b) An estimate of centriole length was obtained from the distance between the centroid of the GT335 spot and the centroid of the CP110 spot. 17 control cells and 27 C2cd3 cells were measured. The asterisks denote a highly significant difference (p<10−4) by Student t-test.
(c) Longitudinal and (d) transverse TEM sections of WT and C2cd3 centrioles. Centrioles from the mutant MEFs appear stunted and lack all appendages (arrows point to subdistal appendages and arrowheads point to distal appendages). Scale bar 100 nm.
(e) Serial transverse TEM sections of WT and C2cd3 centrioles. WT centrioles are contained within 5 to 6 sections whereas C2cd3 centrioles span less than 3 sections. Scale bar 100 nm.
(f) Measurement of centriole length using data collected from 4 WT, 14 +/Gt, 6 C2cd3 and 10 C2cd3 centrioles. The error bar denotes one standard deviation. Three asterisks denote a highly significant difference (p<10−4) by Student t-test and one asterisk a significant difference (p<10−1) by Student t-test.
To gain insight into the mechanisms by which C2cd3 controls centriole length, we examined the effects of overexpressing GFP-C2cd3. Strikingly, in RPE cells, we observed one or two juxtanuclear >2 µm-long straight rods marked by GFP-C2cd3 and acetylated microtubules along their length (Fig. 5a, insets) and resistant to nocodazole treatment (Supplementary Fig. 7a). By synchronizing cells in S and releasing in G2[32], we found that 15 to 25% of U2OS cells transfected with GFP-C2cd3 possessed GFP-positive rods, in line with previously described centriole lengthening activities[31,32]. The morphological resemblance to the hyperelongated centrioles from cells overexpressing CPAP or Cep120 (Ref. 3–5,31,32) hinted that the C2cd3 rods might represent hyperelongated centrioles (Fig. 5b–e). These juxtanuclear C2cd3 rods were positive for CPAP and Cep164 at their base (Fig. 5b and c), glutamylated tubulin and centrin along their length (Fig. 5d and e), and showed an enrichment of CP110 at their distal end (Fig. 5e). The absence of the cilium maker IFT88 from the C2cd3 rods (Fig 5d) and the presence of CP110 at the end of these structures (Fig. 5e) strongly suggested that they represent hyperelongated centrioles and not cilia. To confirm that C2cd3 promotes centriole hyperelongation, we imaged the GFP-C2cd3-positive rods by correlative light-electron microscopy[33] (CLEM) and identified continuous extensions of the centriolar microtubules up to 1.3 µm long in three separate cells (Fig. 5f, Supplementary Fig. 7b and Supplementary Video 1).
Figure 5
Ofd1 antagonizes the centriole-elongating activity of C2cd3
(a) RPE cells transfected with GFP-C2cd3 were stained or acetylated tubulin (red) and DNA (blue). GFP-C2cd3 colocalizes extensively with acetylated microtubules, in particular at two straight juxtanuclear rods (insets). Scale bar 5 µm.
(b–e) U2OS osteosarcoma cells transfected with GFP-C2cd3 and subjected to a block in S phase and release into G2 were stained for CPAP (red, c) and acetylated tubulin (magenta, c), Cep164 (red, d) and acetylated tubulin (magenta, d), glutamylated tubulin (GT335, red, e) and IFT88 (magenta, e) and CP110 (red, f) and centrin (magenta, f). The contrast in the IFT88 channel was maximized to reveal background levels of staining. Scale bars 2 µm.
(f) Correlative light electron microscopy of an elongated GFP-C2cd3 filament connected to the centriole. The centrosomes (arrowhead) were located using a fusion of the Red Fluorescent Protein (RFP) with the Pericentrin/AKAP450 Centrosome Targeting domain (PACT). The cell of interest was first imaged by fluorescence (left panel) and located in thin sections imaged by electron microscopy (right panel). Serial sections were aligned and projected to show centriole hyperelongation (lower panel). Individual sections are shown in Supplementary Figure 7b and Supplementary Video 1. Scale bar 5 µm (upper panels), 200 nm (lower panel).
(g) U2OS osteosarcoma cells were transfected with GFP-C2cd3 alone, GFP-C2cd3 and Myc-Ofd1 or GFP-C2cd3 and an empty Myc plasmid. Cells were stained for Cep164 and Myc and hyperelongated centrioles were scored in cells positive for GFP and Myc. At least 70 cells were counted for each condition. The error bars represent the standard deviations between four independent experiments.
In addition to hyperelongated centrioles, overexpressed GFP-C2cd3 was found alongside bright microtubules rods (Supplementary Fig. 7c) enriched in acetylated tubulin in various regions of the cytoplasm (Fig. 5a). Similar to prior observations with CPAP overexpression[3], CLEM revealed that these cytoplasmic microtubules structures are reminiscent of centrioles, albeit much less organized. The mixed C2cd3/microtubule rods contained microtubules spaced 250nm apart by an electron dense matrix (Fig. 6a) and doublet microtubules could sometime be distinguished (Fig. 6a, lower panel). Congruently, the C2cd3/microtubule rods were positive for centrin (Fig. 6b). While the biogenesis of these centriole-like structures is presently unknown, they may have originated and then broken off from hyperelongated centrioles (see Supplementary Fig. 7b and Supplementary Video 1).
Figure 6
C2cd3 promotes assembly of microtubule structures with centriolar features
(a) CLEM of cytoplasmic GFP-C2cd3 filaments. N, nucleus; m, mitochondria. Scale bar 5 µm (fluorescence panels), 500 nm (EM panels).
(b) U2OS osteosarcoma cells transfected with GFP-C2cd3 were stained for centrin (red), acetylated tubulin (magenta) and DNA (blue). Scale bar 5 µm.
The ability of C2cd3 to induce centriole hyperelongation enabled a test of the functional antagonism between C2cd3 and Ofd1. Co-transfection of Ofd1 –but not of a control plasmid– with C2cd3 led to a drastic reduction in the frequency of hyperelongated centrioles (Fig. 5g). Our finding that the OFD gene products Ofd1 and C2cd3 antagonize one another in centriole length regulation suggests a model where C2cd3 promotes centriole lengthening and Ofd1 inhibits the activity of C2cd3 through direct physical contact. In this model, the inhibition exerted by Ofd1 onto C2cd3 would need to be minimal in the early stages of procentriole elongation and increased as centrioles reach their mature length. Further insights may be gained by studying how the centriole lengthening activity of C2cd3 is related to its suggested ability to bind and stabilize microtubules and how C2cd3 function is coordinated with the procentriole elongating activities of CPAP and Cep120 in particular with respect to their microtubule-stabilizing activities[31,32]. Finally, an unexplored aspect of C2cd3 lies in its six canonical C2 domains which are predicted to bind Ca2+ and phospholipid headgroups[10]. Centrin, which co-localizes precisely with C2cd3 and promotes centriole lengthening, also binds Ca2+ (Ref. 34) and it is tempting to speculate that centriolar Ca2+ levels may regulate centriole elongation.
METHODS
Methods and any associated references are available in the online version of the paper.
Online Methods
Research subjects
The consanguineous family and additional families were recruited worldwide based upon the presence of at least one individual with an OFD syndrome proven with oral features (lingual hamartoma, cleft/lobulated tongue, gingival frenulae, and/or cleft lip/palate), facial dysmorphism, and digital anomalies, as well as Meckel syndrome. Whenever possible, individuals underwent a full diagnostic protocol, and a standardized clinical questionnaire was administered to assess the extent of multi-organ involvement. Informed consent was obtained for all participating patients and their families; the study was approved by the Ethics Boards of Necker-Enfants Malades Hospital (Paris) and Dijon University Hospital. In fetuses, pregnancies were terminated after genetic counselling, in accordance with local legislation. Chromosome analysis and clinicopathological examination were performed for all cases. Genomic DNA was extracted from frozen tissue or amniocyte cultured cells in foetal cases, and from peripheral blood samples for patients and their parents using standard procedures.
Genome-wide SNP genotyping and homozygosity mapping
Genome-wide SNP genotyping was performed using the Human Mapping 500K Nsp Array (Affymetrix, Santa Clara, CA) at the Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC, Illkirsch). Sample processing and labeling were performed according to the manufacturer instructions (Affymetrix GeneChip Mapping 500K Assay Manual, #701930 Rev.3). Hybridization was performed with a GeneChip Hybridization oven 640 at 49°C, 60 rpm for 16 h, washed with a GeneChip Fluidics Station 450, and scanned with a GeneChip Scanner 3000-7G. The image data was processed with the Affymetrix Genotyping Console (GTC v4.1) for determining SNP call and copy-number variation. Homozygosity mapping was performed using HomozygosityMapper[35] default parameters (see URLs).
Exome sequencing
Exome capture was performed at the Genoscope Centre National de Génotypage (CNG, Evry) on 8 µg of DNA sample from the affected proband using SureSelect Human All Exon 50Mb kit (Agilent) according to standard procedures. The resulting libraries underwent 2×100-bp paired-end sequencing on an Illumina HiSeq 2000 in accordance with the manufacturer’s recommendations.Reads were aligned to the human reference genome (GRCh37/hg19) with the Burrows-Wheeler Aligner[36] (BWA.0.5.6) and removed potential duplicate paired-end reads using the picardtools.1.22 (see URLs). The Genome Analysis Toolkit (GATK) 1.0.57 was used for base quality score recalibration and indel realignment, as well as for single-nucleotide variant and indel discovery and genotyping using standard hard filtering parameters[37,38]. Homozygous variants with quality scores of >30, sequencing depth of >4, quality/depth ratio of >5.0 and strand bias of <-0.10 were conserved from subsequent analyses. Coverage was assessed with the GATK Depth of Coverage tool by ignoring reads with mapping quality of <20 and bases with base quality of <30. Candidate events were then inspected using Integrative Genomics Viewer (IGV). The resulting variants were excluded when the frequency was over 1/1000 in the Exome Variant Server, NHLBI (see URLs).
Sanger sequencing validation
Mutation screening of C2CD3 (NM_015531.4) was performed by direct sequencing of PCR products of the 31 coding exons and the adjacent intronic junctions in 34 patients with OFD. PCR primers (sequences available upon request) were designed with Primer3 (Ref. 39, see URLs) according to reference sequence NM_015531.4. PCR products were purified using the Exo-SAP cleanup kit (USB). Sequencing was performed using the ABI BigDye Terminator Cycle Sequencing kit (v3.1) (Applied Biosystems) following the manufacturer’s instructions in an ABI 3130 sequencer 7 (Applied Biosystems). Sequence data were analyzed with SeqScape v2.7 (Applied Biosystems). The impact of the missense and splice-site mutation were assessed using PolyPhen-2 (Ref. 40, see URLs) and the Human Splicing Finder v.2.4.1 online software[41] (see URLs), respectively.
cDNA sequencing
To assess the impact of the c.3911-2A>T substitution on splicing, we extracted total RNA from skin biopsies obtained from patient 2 and two control individuals using the RNeasy Plus Universal Mini Kit (Qiagen), and performed reverse transcription PCR (RT-PCR) using the QuantiTect Reverse Transcription Kit (Qiagen) according to manufacturer's instructions. Analysis of C2CD3 cDNA was carried out by standard PCR amplification using primers between exons 20 and 23 as well as between exons 21 and 23, and subsequent Sanger sequencing as described above.
Cell culture
IMCD3 cells were cultured in DMEM/F12 medium (Life Technologies) containing 10% FBS (HyClone) at 37°C in 5% CO2. The medium was supplemented with 0.25% Na2CO3 for RPE cells. DMEM with 10% FBS was used to grow HEK293FT and SV40-immortalized MEFs derived from C2cd3 mutant mice and C2cd3 heterozygous mice[11]. To induce ciliogenesis, cells were grown in serum starvation medium (0.2% FBS) for 24 hours. A stable IMCD3 clonal cell line expressing GFP-C2cd3 under control of the EF1α promoter was generated using the Flp-In system (Invitrogen), as described previously[20]. Transfections of RPE, IMCD3 and HEK293 cells were carried out with with X-tremeGENE9 (Roche). U2OS cells were transfected with Lipofectamine 2000. To maximize the centriole elongation frequency observed upon C2cd3 overexpression, 48 h after transfection, U2OS cells were arrested in S phase by addition of hydroxyurea (8 mM) or aphidicolin (2 µg/ml) for 20hr then released into G2 by changing the medium to roscovitine (RO-3306, 10 µM) for 16hr before fixing.
Immunoblotting, immunoprecipitation and immunohistochemistry
All antibodies used in this study are listed in Supplementary table 3. Immunofluorescence was conducted as in Ref. 42. Briefly, cells were fixed for 5 min with 4% PFA and immediately plunged in −20°C methanol before rehydration in PBS and processing for immunofluorescence (except for CPAP immunofluorescence for which the PFA step was omitted). For studying the localization of C2cd3 within centrioles (Fig. 2 and Supplementary Fig. 4), cells were treated with 5 µM nocodazole for 1h before processing for immunofluorescence. All microscopy (except for the measurement of centriole length) was performed with a 63× 1.4 N.A. PlanApo objective mounted on a Zeiss Axio Imager.M1 microscope connected to a Lambda XL light source (Sutter Instruments) and fluorescence was gated by a Sedat filter set (Semrock). Images were captured by a CoolSNAP HQ[2] camera (Photometrics) and the system was controlled by Slidebook 5 (Intelligent Imaging Innovations).To measure the distance between CP110 and GT335 in MEF cells, z stack images of centrioles were taken on a DeltaVision workstation (GE) equipped with an Olympus PlanApo 60x/1.42 Oil lens and a sCMOS camera and deconvolved using softWoRx software. Only those centrioles with both CP110 and GT335 in the same focal plane were selected for distance measurement. The center points (centroids) of GT335 and CP110 were mapped using SpotTracker plugin in ImageJ and the distances between these two centroids were measured.Immunoblotting, co-transfection/co-immunoprecipitations and GST capture assays were carried out as before[20,27]. Tandem affinity purification of the BBSome using the RPE-[LAP-BBS4] stable cell line has been described[19].The immunoprecipitation of endogenous Ofd1 was conducted as follows: two 15 cm dishes of RPE cells were lysed in buffer Co-IP 200 (50 mM Tris pH 7.4, 200 mM NaCl, 1% Triton X-100, 1mM DTT), the lysate was cleared by centrifugation at 16,000 x g and 50 ng of Ofd1 antibody or 2 µg of rabbit IgG were added to 5 mg of cell lysate. After 45min incubation at 4 °C, antibody/antigen complexes were captured on 10 µl of protein A-Sepharose beads through end-over-end incubation for 1h. Beads were washed four times with buffer Co-IP 200 and complexes eluted in NuPage LDS sample buffer (247mM Tris base, 2% LDS, 10% Glycerol, 0.51 mM EDTA, 0.22 mM Coomassie G250, 0.175 mM Phenol Red, pH 8.5).
Electron microscopy
Cells were seeded on 8-well Permanox chamber slides (Nalgene Nunc International, Naperville, IL) and were subsequently fixed in 3.5 % glutaraldehyde in 0.1 M phosphate buffer (PB) for 10 minutes at 37 °C, replaced with fresh pre-warmed 3.5% glutaraldehyde and incubated 1 hour at 4 °C. Cells were postfixed in 2% OsO4 for 1 hour at room temperature and stained in 2% uranyl acetate in the dark for 2 h at 4 °C. Finally, cells were rinsed in distilled water, dehydrated in ethanol, and embedded overnight in Durcupan resin (Fluka, Sigma-Aldrich, St. Louis, USA). Following polymerization, serial ultrathin sections (0.06 – 0.08 µm) were cut with an UC-6 Ultracut (Leica, Heidelberg, Germany) and stained with lead citrate. Photomicrographs were obtained under a FEI Tecnai G2 Spirit transmission electron microscope (FEI Europe, Eindhoven, Netherlands) using a Morada digital camera (Olympus Soft Image Solutions GmbH, Münster, Germany). Quantitative measurements of centriole length were determined in longitudinal sections using Fiji.
Correlative Light-Electron Microscopy (CLEM)
U2OS cells were seeded onto photo-etched gridded coverslips (Bellco) and transfected with pEGFP-C2cd3 either alone or in combination with pRFP-PACT. 48h after transfection, cells were fixed with glutaraldehyde as above and the regions of interest (ROIs) were identified on an inverted fluorescence microscope (Deltavision, GE Healthcare). The coordinates of each ROI were recorded at low magnification to enable identification of the ROI after embedding. Processing of samples for EM was performed as above except for the insertion of a block trimming step as described in [33]. Serial sections were aligned using the TrakEM2 plugin [43] from Fiji [44].
Authors: Aaron McKenna; Matthew Hanna; Eric Banks; Andrey Sivachenko; Kristian Cibulskis; Andrew Kernytsky; Kiran Garimella; David Altshuler; Stacey Gabriel; Mark Daly; Mark A DePristo Journal: Genome Res Date: 2010-07-19 Impact factor: 9.043
Authors: Andrea Poretti; Giuseppina Vitiello; Raoul C M Hennekam; Filippo Arrigoni; Enrico Bertini; Renato Borgatti; Francesco Brancati; Stefano D'Arrigo; Francesca Faravelli; Lucio Giordano; Thierry A G M Huisman; Miriam Iannicelli; Gerhard Kluger; Marten Kyllerman; Magnus Landgren; Melissa M Lees; Lorenzo Pinelli; Romina Romaniello; Ianina Scheer; Christoph E Schwarz; Ronen Spiegel; Daniel Tibussek; Enza Maria Valente; Eugen Boltshauser Journal: Orphanet J Rare Dis Date: 2012-01-11 Impact factor: 4.123
Authors: Hua Jin; Susan Roehl White; Toshinobu Shida; Stefan Schulz; Mike Aguiar; Steven P Gygi; J Fernando Bazan; Maxence V Nachury Journal: Cell Date: 2010-06-25 Impact factor: 41.582
Authors: Jun Chul Kim; Jose L Badano; Sonja Sibold; Muneer A Esmail; Josephine Hill; Bethan E Hoskins; Carmen C Leitch; Kerrie Venner; Stephen J Ansley; Alison J Ross; Michel R Leroux; Nicholas Katsanis; Philip L Beales Journal: Nat Genet Date: 2004-04-25 Impact factor: 38.330
Authors: M I Ferrante; G Giorgio; S A Feather; A Bulfone; V Wright; M Ghiani; A Selicorni; L Gammaro; F Scolari; A S Woolf; O Sylvie; L Bernard; S Malcolm; R Winter; A Ballabio; B Franco Journal: Am J Hum Genet Date: 2001-02-13 Impact factor: 11.025
Authors: Mark A DePristo; Eric Banks; Ryan Poplin; Kiran V Garimella; Jared R Maguire; Christopher Hartl; Anthony A Philippakis; Guillermo del Angel; Manuel A Rivas; Matt Hanna; Aaron McKenna; Tim J Fennell; Andrew M Kernytsky; Andrey Y Sivachenko; Kristian Cibulskis; Stacey B Gabriel; David Altshuler; Mark J Daly Journal: Nat Genet Date: 2011-04-10 Impact factor: 38.330
Authors: David K Breslow; Elena F Koslover; Federica Seydel; Andrew J Spakowitz; Maxence V Nachury Journal: J Cell Biol Date: 2013-10-07 Impact factor: 10.539
Authors: Myriam Srour; Fadi F Hamdan; Dianalee McKnight; Erica Davis; Hanna Mandel; Jeremy Schwartzentruber; Brissa Martin; Lysanne Patry; Christina Nassif; Alexandre Dionne-Laporte; Luis H Ospina; Emmanuelle Lemyre; Christine Massicotte; Rachel Laframboise; Bruno Maranda; Damian Labuda; Jean-Claude Décarie; Françoise Rypens; Dorith Goldsher; Catherine Fallet-Bianco; Jean-François Soucy; Anne-Marie Laberge; Catalina Maftei; Kym Boycott; Bernard Brais; Renée-Myriam Boucher; Guy A Rouleau; Nicholas Katsanis; Jacek Majewski; Orly Elpeleg; Mary K Kukolich; Stavit Shalev; Jacques L Michaud Journal: Am J Hum Genet Date: 2015-10-17 Impact factor: 11.025
Authors: Rory J Olson; Katharina Hopp; Harrison Wells; Jessica M Smith; Jessica Furtado; Megan M Constans; Diana L Escobar; Aron M Geurts; Vicente E Torres; Peter C Harris Journal: J Am Soc Nephrol Date: 2019-08-19 Impact factor: 10.121
Authors: Heather E Olson; Nolwenn Jean-Marçais; Edward Yang; Delphine Heron; Katrina Tatton-Brown; Paul A van der Zwaag; Emilia K Bijlsma; Bryan L Krock; E Backer; Erik-Jan Kamsteeg; Margje Sinnema; Margot R F Reijnders; David Bearden; Amber Begtrup; Aida Telegrafi; Roelineke J Lunsing; Lydie Burglen; Gaetan Lesca; Megan T Cho; Lacey A Smith; Beth R Sheidley; Christelle Moufawad El Achkar; Phillip L Pearl; Annapurna Poduri; Cara M Skraban; Jennifer Tarpinian; Addie I Nesbitt; Dietje E Fransen van de Putte; Claudia A L Ruivenkamp; Patrick Rump; Nicolas Chatron; Isabelle Sabatier; Julitta De Bellescize; Laurent Guibaud; David A Sweetser; Jessica L Waxler; Klaas J Wierenga; Jean Donadieu; Vinodh Narayanan; Keri M Ramsey; Caroline Nava; Jean-Baptiste Rivière; Antonio Vitobello; Frédéric Tran Mau-Them; Christophe Philippe; Ange-Line Bruel; Yannis Duffourd; Laurel Thomas; Stefan H Lelieveld; Janneke Schuurs-Hoeijmakers; Han G Brunner; Boris Keren; Julien Thevenon; Laurence Faivre; Gary Thomas; Christel Thauvin-Robinet Journal: Am J Hum Genet Date: 2018-04-12 Impact factor: 11.025
Authors: Kurt Reynolds; Shuwen Zhang; Bo Sun; Michael A Garland; Yu Ji; Chengji J Zhou Journal: Birth Defects Res Date: 2020-07-15 Impact factor: 2.344
Authors: Nicole J Boczek; Katharina Hopp; Lacey Benoit; Daniel Kraft; Margot A Cousin; Patrick R Blackburn; Charles D Madsen; Gavin R Oliver; Asha A Nair; Jie Na; Diana W Bianchi; Geoffrey Beek; Peter C Harris; Pavel Pichurin; Eric W Klee Journal: Eur J Hum Genet Date: 2018-08-10 Impact factor: 4.246